Igm Biosciences

Developer of engineered IgM antibodies for the treatment of cancer patients

placeMountain View, California, United States calendar_todayFounded 2010 groups181 employees language igmbio.com

Registered entities

Investor mix

4 investors on record; lead investors include Redmile Group, Janus Henderson Investors, Vivo Capital.

Investor typeCountShare
Venture capital125%
Private equity125%
Other / undisclosed250%
Coming soon